REG - Dr. Martens PLC - EBT Share Purchase

Dr MartensAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260519:nRSS7987Ea&default-theme=true

RNS Number : 7987E  Dr. Martens PLC  19 May 2026

Dr. Martens plc (the "Company")

EBT Share Purchase

The Company announces that it has recommended that FCM Trust Limited (the
"Trustee"), in its capacity as trustee of the Dr Martens plc Employee Benefit
Trust (the "Trust"), purchases up to 10m ordinary shares of the Company in the
market, with the purchases commencing as soon as is practicable.

The shares will be held on an unallocated basis for use in satisfying both
current and future awards under the Company's employee share plans from time
to time.

 

Enquiries:

Bethany Barnes, Director of Investor Relations & Corporate
Communications

+44 7825 187465

bethany.barnes@drmartens.com (mailto:bethany.barnes@drmartens.com)

 

Paul Rolling, Head of Secretariat

+44 (0)7584 243562

paul.rolling@drmartens.com (mailto:paul.rolling@drmartens.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCSFWFWAEMSESI



            Copyright 2019 Regulatory News Service, all rights reserved